Tumor cell free DNA in kidney cancer and the OPTIC-RCC trial
In this episode from "The Uromigos” podcast that aired on 11/14/22, Dr. Scott Haake discusses tumor cell free DNA in kidney cancer as well as the OPTIC-RCC trial.
2022 KidneyCAN Kidney Cancer Research Forum
In this talk from the 2022 KidneyCAN Kidney Cancer Research Forum, Dr. Anupama Reddy discusses the bioinformatics behind the OPTIC-RCC clinical trial. Dr. Haake's portion…
Grant supports Haake’s research on kidney cancer
Kure It Cancer Research has awarded a $200,000 grant to support the work of Scott Haake, MD, assistant professor of Medicine in the Division of Hematology and Oncology.
Monitoring Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
In this talk for the 2021 Vanderbilt Translational Research Forum, Dr. Scott Haake discusses tumor cell free DNA in kidney cancer.
KCRS21: Innovative non-immune therapy related therapeutics and monitoring
In this talk for the 2021 KidneyCAN Kidney Cancer Research Forum, Dr. Scott Haake discusses tumor cell free DNA in kidney cancer. His talk begins at 31:27.